Investing in health and environment

The main event of Oslo Life Science 2018 where we showcase our best research and let international speakers give us new insight in how to increase value creation from basic research. What are the government’s expectations for the life science community in the Oslo region?

Fill out the form at the bottom of the page to sign up.

Target groups: researchers, students, bureaucrats, businesspeople, investors and politicians. 

You will meet

 

Haddy Njie

 

Chair

Professor Svein Stølen, Rector of the University of Oslo 

Knowledge in use – science, collaboration and impact

 

TBA

What does the government expect from the life science community in the Oslo region?

This autumn the minister of research and education announced that the starting grant for the planned life science building at UiO would be on the 2018 national budget. He stated that the government has great expectations about what this building will mean for Norway.

Dr., MBA Barbara Nelsen

Founder of Nelsen Biomedical. Nelsen has extensive experience in moving technology from concept to commercialization, developing business models, implementing business plans, and creating strategic partnerships and market expansion activities. She has been an investor and a scientific investigator and has worked in the industry in both research and development and in business development.

How novel technologies move from the institute to the market

Professor Craig Garner, founder and director of SPARK Berlin, the first SPARK site in Europe, and former Standford SPARKee

The SPARK concept to enhance innovation in Europe and worldwide

Gunnveig Grødeland, researcher Institute of Clinical Medicine, Faculty of Medicine, UiO and one of the first five Norwegian SPARKees

How can SPARK Norway help take our idea to the market?

Professor P. Wenzel Geissler, Department of Social Anthropology, Faculty of Social Sciences, UiO

Professor Katrine Borgå, Department of Biosciences, The Faculty of Mathematics and Natural Sciences, UiO

Researcher Irep Gözen, Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine and Department of Chemistry, Faculty of Mathematics and Natural Sciences, UiO

Researcher, Gry Oftedal, Department of Philosophy, Classics, History of Arts and Ideas, Faculty of Humanities, UiO

Professor II, Arne Klungland, Institute of Basic Medical Sciences, Faculty of Medicine and Clinic for Laboratory Medicine (KLM), Oslo University Hospital(OUS) 

Associate Professor Shuo-Wang Qiao, Institute of Clinical Medicine, Faculty of Medicine, UiO

Associate Professor Steven Wilson, Associate Professor, Department of Chemistry, Faculty of Mathematics and Natural Sciences, UiO

Professor Anne Danielsen, Director RITMO, Department of Musicology, Faculty of Humanities, UiO

Associate Professor Alexander Refsum Jensenius, Deputy Director RITMO, Department of Musicology, Faculty of Humanities, UiO

Tarje Bergdahl, Head Medical Affairs, Novartis

CAR-T: Bench to bedside to factory

Professor Mari Sundli Tveit, Rector of the Norwegian University of Life Science(NMBU)

Investing in a sustainable future

Disease modelling and demography (tentative title)

Bjørn Erikstein, CEO Oslo University Hospital

Strengthening clinical research in Oslo University Hospital

Raymond Johansen, Governing Mayor, the City of Oslo

A campus strategy for Oslo

Professor Finn-Eirik Johansen, chairperson of the UiO:Life Science board

Closing remarks

Sign up for this event

Published June 23, 2017 12:24 PM - Last modified Jan. 22, 2018 8:12 AM